Efficacy of embolo/sclerotherapy in the treatment of high-output cardiac failure caused by peripheral arteriovenous malformations
This study provides evidence that embolo/sclerotherapy effectively treats pAVMs with associated HOCF by reducing abnormal blood flow and significantly improving symptoms. The results also reveal a linear relationship between the decrease in venous drainage pressure and improvement in LVEF in patients with HOCF caused by pAVMs after embolo/sclerotherapy.
Authors
- Zhidong Ye (ORCID: https://orcid.org/0000-0002-1282-3261)
- Bin Ni (ORCID: https://orcid.org/0000-0002-1412-2901)
- Qiangqiang Nie (ORCID: https://orcid.org/0000-0002-0101-6173)
- Xueqiang Fan (ORCID: https://orcid.org/0009-0004-5294-5396)
- Xixi Guo
- Yuguang Yang
- Kai Zheng
- Peng Liu (ORCID: https://orcid.org/0009-0007-7328-6192)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3389/fcvm.2025.1592077
- Citations
- 2
- Primary Topic
- Vascular Malformations Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.78